Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - Annals of Oncology
Overall survival in metastatic renal cell carcinoma patients after... | Download Scientific Diagram
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
xmlinkhub
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
EAU 2021: Evolving Landscape of First-Line Systemic Treatment in Metastatic Renal Cell Carcinoma
